NorthWest Biotherapeutics Inc (NWBO)

[alphapuppy]

Thanks abeta. I am not sure if I can link the abstracts as I have to login to my ASCO account in order to access them.

I apologize for the negativity of my prior post, however given my own and yours and others such as leprechauns analysis and modeling, there is a very very high probability currently and there has been for a long time that we have a positive result with the current randomized trial.

I believe that Linda is getting some very bad and very poor statistical advice at this point. I fear that she is thinking about this like a lawyer would think about a case going to trial and wants to leave no stone unturned No matter how long it takes.

The thing that I believe she’s not considering as much as she should, is the recognition that there is also a significant risk also to waiting to long. It’s a risk in terms of financing for her company, but more importantly a risk to patients who have the disease and cannot receive this therapy that would help them. In addition NWBO has lost the opportunity and marketing advantages of being able to Present Their data, at a major meeting such as ASCO with a late breaking abstract At the plenary session to 1000s of oncologist in attendance.

Clearly the cost benefit ratio now would favor Unblinding And releasing top line immediately. Further follow up for patients will only produce very minuscule Statistically insignificant changes from what is currently available with the current follow up.

With as much follow-up as they currently have now for their patients in the trial, continuing to keep the trial from being unblinded will only yield very very minimal improvements compared to what is already the results of the trial with the Lengthy follow up we currently already have.